|
ZNF718 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.140500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.296800E-01 |
| Normal-vs-Stage2 |
6.242200E-01 |
| Normal-vs-Stage3 |
5.61919999999549E-05 |
| Normal-vs-Stage4 |
1.70019999999882E-05 |
| Stage1-vs-Stage2 |
9.972800E-01 |
| Stage1-vs-Stage3 |
3.043400E-04 |
| Stage1-vs-Stage4 |
5.73579999999518E-05 |
| Stage2-vs-Stage3 |
5.682400E-02 |
| Stage2-vs-Stage4 |
3.857800E-02 |
| Stage3-vs-Stage4 |
7.938800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.418600E-03 |
| Normal-vs-AfricanAmerican |
8.533700E-02 |
| Normal-vs-Asian |
2.389400E-01 |
| Caucasian-vs-AfricanAmerican |
8.095200E-01 |
| Caucasian-vs-Asian |
8.969600E-01 |
| AfricanAmerican-vs-Asian |
9.764200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.559400E-03 |
| Normal-vs-Female |
7.258400E-02 |
| Male-vs-Female |
2.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.337270E-03 |
| Normal-vs-Age(41-60Yrs) |
1.063630E-01 |
| Normal-vs-Age(61-80Yrs) |
5.218000E-03 |
| Normal-vs-Age(81-100Yrs) |
5.963400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.267700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.187400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.818800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.491600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.977440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.227800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.522590E-01 |
| Normal-vs-Grade 2 |
9.288400E-01 |
| Normal-vs-Grade 3 |
3.78290000000447E-05 |
| Normal-vs-Grade 4 |
3.22519999595983E-09 |
| Grade 1-vs-Grade 2 |
1.352560E-01 |
| Grade 1-vs-Grade 3 |
6.248600E-04 |
| Grade 1-vs-Grade 4 |
1.43210000003169E-06 |
| Grade 2-vs-Grade 3 |
2.1161999999908E-05 |
| Grade 2-vs-Grade 4 |
2.23880003424881E-09 |
| Grade 3-vs-Grade 4 |
5.862200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.852800E-01 |
| Normal-vs-ccB subtype |
8.962600E-04 |
| ccA subtype-vs-ccB subtype |
1.141000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.763940E-02 |
| Normal-vs-N1 |
1.193350E-04 |
| N0-vs-N1 |
6.800700E-03 |
|
|
